Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPHK2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SRRM4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | TMEM89 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CCAR2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CDC7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | VPS37D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZMYM2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | USP13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CTNNA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GHITM | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |